Conmed (NYSE: CNMD) released Q4 results that missed Wall Street projections by a wide margin due to a previously disclosed warehouse problem. The Largo, Florida–based maker of surgical and patient monitoring products and services earned $26.6 million, or 86¢ per share, off of $250.9 million in sales for the quarter that ended Dec. 31, 2022. […]
Conmed
Conmed pulls 2022 guidance due to software implementation
Conmed (NYSE:CNMD) announced today that it is withdrawing its full-year outlook over problems implementing software at its main distribution facility. Largo, Florida-based Conmed last month issued its guidance with a reduction from previous projections. This came on the back of an underwhelming third-quarter performance that saw its stock dip by nearly 8%. However, shares of […]
Conmed stock slides on Q3 revenue miss, slashed EPS guidance
Conmed (NYSE:CNMD) shares took a hit today on third-quarter results that missed the consensus revenue forecast. CNMD shares fell 7.8% to $77.15 apiece in morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up more than 1%. Despite the revenue miss and EPS guidance cut, […]
Conmed to acquire bioinductive scaffold startup Biorez
Conmed (NYSE:CNMD) this week announced a definitive agreement to acquire medtech startup Biorez. The company will acquire Biorez to enhance its sports medicine soft tissue healing portfolio. It plans to acquire the company on a cash-free, debt-free basis, for a cash consideration of $85 million at closing with up to an additional $165 million in growth-based […]
Conmed stock dips on lowered guidance despite Street-beating Q2
Conmed (NYSE:CNMD) shares are down today on lowered 2022 guidance, even as its Q2 results beat Wall Street expectations. The Largo, Florida–based company posted losses of $168.3 million, or $5.65 per share, on sales of $277.2 million for the three months ended June 30, 2022, for a massive bottom-line slide deep into the red on […]
Conmed completes $145M In2Bones acquisition
Conmed (NYSE:CNMD) announced today that it completed its previously announced acquisition of In2Bones Global. Largo, Florida–based Conmed announced last month that it intended to acquire upper extremities device maker In2Bones Global for $145 million. The $145 million figure was floated for the closing of the acquisition, with up to an additional $110 million in growth-based […]
Conmed beats The Street in Q1, announces $145M deal to acquire In2Bones
Conmed (NSDQ:CNMD) announced that it will acquire In2Bones Global for more than $145 million after it posted first-quarter results that beat the overall consensus on Wall Street. The Largo, Florida–based minimally invasive medical device company on yesterday evening reported profits of $14.96 million, or 47¢ per share, on sales of $242.3 million for the three […]
The best places to work for medtech sales reps in 2022
Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and Medtronic (NYSE:MDT) topped the list of best places to work in medtech sales in 2022, according to a MedReps.com survey of medical sales representatives. The 11th annual MedReps survey polled over 2,300 MedReps professionals to determine which medtech sales companies are most sought-after in the industry. Overall, pay and leadership were the most important […]
Conmed posts mixed-bag Q3 results
ConMed (NSDQ:CNMD) this week posted third-quarter results that beat the earning consensus on Wall Street but missed on revenue estimates. The Largo, Florida-based minimally invasive surgical device company reported profits of $14.9 million, or 47¢ per share, on sales of $248.8 million for the three months ended September 30, for a bottom-line gain of 118.2% on […]